Brief: CK Life Sciences Intl (Holdings) Says HY Profit Attributable Up 15%
Aug 3 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* HY PROFIT ATTRIBUTABLE OF AROUND HK$100 MILLION, UP 15%
* HY REVENUE HK$2.64 BILLION VERSUS HK$2.38 BILLION
Source text for Eikon: ID:nHKS8JKtg6
Further company coverage: 0775.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development